Catalio Capital Management, LP
SEC-registered investment adviser.
- Website
- https://cataliocapital.com
- HQ
- NY
Catalio Capital Management invests in innovative healthcare companies at all stages and sizes, across the capital structure. Its leadership includes co-founders George C. Petrocheilos and R. Jacob Vogelstein, Ph.D. Portfolio companies named in the facts include ArriVent, Audicus, Bayesian Health, Abridge, AdvanCell, Alentis Therapeutics, and Hippocratic AI.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Healthtech, Digital health, Biotech, Medical devices, Life sciences and research tools | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Catalio Access Fund XII, LLC Catalio invests in innovative healthcare companies at all stages and sizes, across the capital structure. Its portfolio spans drugs, devices, diagnostics and AI-enabled companies, sourced partly through serial scientist-entrepreneur venture partners. Inferred from the firm's website | 2026 | $20.14M (Form D) | Open, writing first checks |
| Catalio Access Fund XI, LLC Catalio invests in innovative healthcare companies at all stages and sizes, across the capital structure. Its portfolio spans drugs, devices, diagnostics and AI-enabled companies, sourced partly through serial scientist-entrepreneur venture partners. Inferred from the firm's website | 2026 | $16.3M (Form D) | Open, writing first checks |
| Catalio Access Fund X, LLC Catalio invests in innovative healthcare companies at all stages and sizes, across the capital structure. Its portfolio spans drugs, devices, diagnostics and AI-enabled companies, sourced partly through serial scientist-entrepreneur venture partners. Inferred from the firm's website | 2026 | $20.25M (Form D) | Open, writing first checks |
| Catalio Access Fund IX, LLC Catalio invests in innovative healthcare companies at all stages and sizes, across the capital structure. Its portfolio spans drugs, devices, diagnostics and AI-enabled companies, sourced partly through serial scientist-entrepreneur venture partners. Inferred from the firm's website | 2026 | $17.34M (Form D) | Open, writing first checks |
| Catalio Access Fund VIII, LLC Catalio invests in innovative healthcare companies at all stages and sizes, across the capital structure. Its portfolio spans drugs, devices, diagnostics and AI-enabled companies, sourced partly through serial scientist-entrepreneur venture partners. Inferred from the firm's website | 2026 | $25M (Form D) | Open, writing first checks |
| Catalio Genesis Fund X, LLC Invests in innovative healthcare companies at all stages, from inception to IPO, focusing on drugs, devices, diagnostics and data. Often backs companies founded by world-renowned serial scientist-entrepreneurs with strong IP. Inferred from the firm's website | 2026 | $19.1M (Form D) | Open, writing first checks |
| Catalio Genesis Fund IX, LLC Catalio invests in innovative healthcare companies at all stages and sizes, across the capital structure. Its portfolio spans drugs, devices, diagnostics and AI-enabled companies, sourced partly through serial scientist-entrepreneur venture partners. Inferred from the firm's website | 2025 | $8.63M (Form D) | Open, writing first checks |
| Catalio Genesis Fund VI, LLC Invests in innovative healthcare companies at all stages, from inception to IPO, focusing on drugs, devices, diagnostics and data. Often backs companies founded by world-renowned serial scientist-entrepreneurs with strong IP. Inferred from the firm's website | 2025 | $15.5M (Form D) | Open, writing first checks |
| Catalio Genesis Fund VIII, LLC Invests in innovative healthcare companies at all stages, from inception to IPO, focusing on drugs, devices, diagnostics and data. Often backs companies founded by world-renowned serial scientist-entrepreneurs with strong IP. Inferred from the firm's website | 2025 | $15.25M (Form D) | Open, writing first checks |
| Catalio Access Fund VII, LLC Catalio invests in innovative healthcare companies at all stages and sizes, across the capital structure. Its portfolio spans drugs, devices, diagnostics and AI-enabled companies, sourced partly through serial scientist-entrepreneur venture partners. Inferred from the firm's website | 2024 | $5M (Form D) | Open, writing first checks |
| Catalio Genesis Fund V, LLC Invests in innovative healthcare companies at all stages, from inception to IPO, focusing on drugs, devices, diagnostics and data. Often backs companies founded by world-renowned serial scientist-entrepreneurs with strong IP. Inferred from the firm's website | 2024 | $11.48M (Form D) | Open, writing first checks |
| Catalio Access Fund VI, LLC Catalio invests in innovative healthcare companies at all stages and sizes, across the capital structure. Its portfolio spans drugs, devices, diagnostics and AI-enabled companies, sourced partly through serial scientist-entrepreneur venture partners. Inferred from the firm's website | 2022 | $8.22M to $8.27M (Form D and SEC adviser filing) | Late investment period |
| Catalio Genesis Fund IV, LLC Catalio invests in innovative healthcare companies at all stages and sizes, across the capital structure. Its portfolio spans drugs, devices, diagnostics and AI-enabled companies, sourced partly through serial scientist-entrepreneur venture partners. Inferred from the firm's website | 2022 | $10.05M to $11.31M (Form D and SEC adviser filing) | Late investment period |
| Catalio Genesis Fund III, LLC Catalio invests in innovative healthcare companies at all stages and sizes, across the capital structure. Its portfolio spans drugs, devices, diagnostics and AI-enabled companies, sourced partly through serial scientist-entrepreneur venture partners. Inferred from the firm's website | 2021 | $35M to $35.78M (Form D and SEC adviser filing) | Late investment period |
| Catalio Access Fund V, LLC | 2021 | $16.11M (Form D) | Follow-ons only |
| Catalio Genesis Fund II, LLC | 2021 | $46.2M (Form D) | Follow-ons only |
| Catalio Nexus Fund III, LP | 2021 | $383.83M (Form D) | Follow-ons only |
| CATALIO ACCESS FUND IV, LLC | 2021 | $14.9M (Form D) | Follow-ons only |
03 · People across funds
- George Petrocheilos
Catalio Access Fund XII, LLC (Named on Form D); Catalio Access Fund XI, LLC (Named on Form D); Catalio Access Fund X, LLC (Named on Form D); Catalio Access Fund IX, LLC (Named on Form D); Catalio Access Fund VIII, LLC (Named on Form D); Catalio Genesis Fund X, LLC (Named on Form D); Catalio Genesis Fund IX, LLC (Named on Form D); Catalio Genesis Fund VI, LLC (Named on Form D); Catalio Genesis Fund VIII, LLC (Named on Form D); Catalio Access Fund VII, LLC (Named on Form D); Catalio Genesis Fund V, LLC (Named on Form D)
- Georgios Petrocheilos, Manager and Member of Manager of the Issuer
Catalio Access Fund VI, LLC (Named on Form D); Catalio Genesis Fund IV, LLC (Named on Form D); Catalio Genesis Fund III, LLC (Named on Form D); Catalio Access Fund V, LLC (Named on Form D); Catalio Genesis Fund II, LLC (Named on Form D); Catalio Nexus Fund III, LP (Named on Form D); CATALIO ACCESS FUND IV, LLC (Named on Form D)
- R. Vogelstein, Manager and Member of Manager of the Issuer
Catalio Access Fund XII, LLC (Named on Form D); Catalio Access Fund XI, LLC (Named on Form D); Catalio Access Fund X, LLC (Named on Form D); Catalio Access Fund IX, LLC (Named on Form D); Catalio Access Fund VIII, LLC (Named on Form D); Catalio Genesis Fund X, LLC (Named on Form D); Catalio Genesis Fund IX, LLC (Named on Form D); Catalio Genesis Fund VI, LLC (Named on Form D); Catalio Genesis Fund VIII, LLC (Named on Form D); Catalio Access Fund VII, LLC (Named on Form D); Catalio Access Fund V, LLC (Named on Form D); Catalio Genesis Fund II, LLC (Named on Form D); Catalio Nexus Fund III, LP (Named on Form D)
- Rachel Vogelstein, Manager and Member of Manager of the Issuer
Catalio Genesis Fund V, LLC (Named on Form D); Catalio Access Fund VI, LLC (Named on Form D); Catalio Genesis Fund IV, LLC (Named on Form D); Catalio Genesis Fund III, LLC (Named on Form D); CATALIO ACCESS FUND IV, LLC (Named on Form D)
- Ben Snedeker, Partner & Head of Public Equities
Catalio Access Fund XII, LLC (Team); Catalio Access Fund XI, LLC (Team); Catalio Access Fund X, LLC (Team); Catalio Access Fund IX, LLC (Team); Catalio Access Fund VIII, LLC (Team); Catalio Genesis Fund X, LLC (Team); Catalio Genesis Fund IX, LLC (Team); Catalio Genesis Fund VI, LLC (Team); Catalio Genesis Fund VIII, LLC (Team); Catalio Access Fund VII, LLC (Team); Catalio Genesis Fund V, LLC (Team); Catalio Access Fund VI, LLC (Team); Catalio Genesis Fund IV, LLC (Team); Catalio Genesis Fund III, LLC (Team); Catalio Access Fund V, LLC (Team); Catalio Genesis Fund II, LLC (Team); Catalio Nexus Fund III, LP (Team); CATALIO ACCESS FUND IV, LLC (Team)
- Diamantis Xylas, M.D., Partner & Co-Head of Private Equity
Catalio Access Fund XII, LLC (Team); Catalio Access Fund XI, LLC (Team); Catalio Access Fund X, LLC (Team); Catalio Access Fund IX, LLC (Team); Catalio Access Fund VIII, LLC (Team); Catalio Genesis Fund X, LLC (Team); Catalio Genesis Fund IX, LLC (Team); Catalio Genesis Fund VI, LLC (Team); Catalio Genesis Fund VIII, LLC (Team); Catalio Access Fund VII, LLC (Team); Catalio Genesis Fund V, LLC (Team); Catalio Access Fund VI, LLC (Team); Catalio Genesis Fund IV, LLC (Team); Catalio Genesis Fund III, LLC (Team); Catalio Access Fund V, LLC (Team); Catalio Genesis Fund II, LLC (Team); Catalio Nexus Fund III, LP (Team); CATALIO ACCESS FUND IV, LLC (Team)
- George C. Petrocheilos, Co-Founder & Managing Partner
Catalio Access Fund XII, LLC (Team); Catalio Access Fund XI, LLC (Team); Catalio Access Fund X, LLC (Team); Catalio Access Fund IX, LLC (Team); Catalio Access Fund VIII, LLC (Team); Catalio Genesis Fund X, LLC (Team); Catalio Genesis Fund IX, LLC (Team); Catalio Genesis Fund VI, LLC (Team); Catalio Genesis Fund VIII, LLC (Team); Catalio Access Fund VII, LLC (Team); Catalio Genesis Fund V, LLC (Team); Catalio Access Fund VI, LLC (Team); Catalio Genesis Fund IV, LLC (Team); Catalio Genesis Fund III, LLC (Team); Catalio Access Fund V, LLC (Team); Catalio Genesis Fund II, LLC (Team); Catalio Nexus Fund III, LP (Team); CATALIO ACCESS FUND IV, LLC (Team)
- Jim Allison, Ph.D., Venture Partner
Catalio Access Fund XII, LLC (Team); Catalio Access Fund XI, LLC (Team); Catalio Access Fund X, LLC (Team); Catalio Access Fund IX, LLC (Team); Catalio Access Fund VIII, LLC (Team); Catalio Genesis Fund X, LLC (Team); Catalio Genesis Fund IX, LLC (Team); Catalio Genesis Fund VI, LLC (Team); Catalio Genesis Fund VIII, LLC (Team); Catalio Access Fund VII, LLC (Team); Catalio Genesis Fund V, LLC (Team); Catalio Access Fund VI, LLC (Team); Catalio Genesis Fund IV, LLC (Team); Catalio Genesis Fund III, LLC (Team); Catalio Access Fund V, LLC (Team); Catalio Genesis Fund II, LLC (Team); Catalio Nexus Fund III, LP (Team); CATALIO ACCESS FUND IV, LLC (Team)
- John Henry Iucker, CFA, Partner & Head of Credit
Catalio Access Fund XII, LLC (Team); Catalio Access Fund XI, LLC (Team); Catalio Access Fund X, LLC (Team); Catalio Access Fund IX, LLC (Team); Catalio Access Fund VIII, LLC (Team); Catalio Genesis Fund X, LLC (Team); Catalio Genesis Fund IX, LLC (Team); Catalio Genesis Fund VI, LLC (Team); Catalio Genesis Fund VIII, LLC (Team); Catalio Access Fund VII, LLC (Team); Catalio Genesis Fund V, LLC (Team); Catalio Access Fund VI, LLC (Team); Catalio Genesis Fund IV, LLC (Team); Catalio Genesis Fund III, LLC (Team); Catalio Access Fund V, LLC (Team); Catalio Genesis Fund II, LLC (Team); Catalio Nexus Fund III, LP (Team); CATALIO ACCESS FUND IV, LLC (Team)
- Matthew Hobson, Ph.D., Principal
Catalio Access Fund XII, LLC (Team); Catalio Access Fund XI, LLC (Team); Catalio Access Fund X, LLC (Team); Catalio Access Fund IX, LLC (Team); Catalio Access Fund VIII, LLC (Team); Catalio Genesis Fund X, LLC (Team); Catalio Genesis Fund IX, LLC (Team); Catalio Genesis Fund VI, LLC (Team); Catalio Genesis Fund VIII, LLC (Team); Catalio Access Fund VII, LLC (Team); Catalio Genesis Fund V, LLC (Team); Catalio Access Fund VI, LLC (Team); Catalio Genesis Fund IV, LLC (Team); Catalio Genesis Fund III, LLC (Team); Catalio Access Fund V, LLC (Team); Catalio Genesis Fund II, LLC (Team); Catalio Nexus Fund III, LP (Team); CATALIO ACCESS FUND IV, LLC (Team)
- Olga Maltseva, Partner & Head of Operations
Catalio Access Fund XII, LLC (Team); Catalio Access Fund XI, LLC (Team); Catalio Access Fund X, LLC (Team); Catalio Access Fund IX, LLC (Team); Catalio Access Fund VIII, LLC (Team); Catalio Genesis Fund X, LLC (Team); Catalio Genesis Fund IX, LLC (Team); Catalio Genesis Fund VI, LLC (Team); Catalio Genesis Fund VIII, LLC (Team); Catalio Access Fund VII, LLC (Team); Catalio Genesis Fund V, LLC (Team); Catalio Access Fund VI, LLC (Team); Catalio Genesis Fund IV, LLC (Team); Catalio Genesis Fund III, LLC (Team); Catalio Access Fund V, LLC (Team); Catalio Genesis Fund II, LLC (Team); Catalio Nexus Fund III, LP (Team); CATALIO ACCESS FUND IV, LLC (Team)
- R. Jacob Vogelstein, Ph.D., Co-Founder & Managing Partner
Catalio Access Fund XII, LLC (Team); Catalio Access Fund XI, LLC (Team); Catalio Access Fund X, LLC (Team); Catalio Access Fund IX, LLC (Team); Catalio Access Fund VIII, LLC (Team); Catalio Genesis Fund X, LLC (Team); Catalio Genesis Fund IX, LLC (Team); Catalio Genesis Fund VI, LLC (Team); Catalio Genesis Fund VIII, LLC (Team); Catalio Access Fund VII, LLC (Team); Catalio Genesis Fund V, LLC (Team); Catalio Access Fund VI, LLC (Team); Catalio Genesis Fund IV, LLC (Team); Catalio Genesis Fund III, LLC (Team); Catalio Access Fund V, LLC (Team); Catalio Genesis Fund II, LLC (Team); Catalio Nexus Fund III, LP (Team); CATALIO ACCESS FUND IV, LLC (Team)
- Sarah Saraiva, CPA, Principal & Head of Finance
Catalio Access Fund XII, LLC (Team); Catalio Access Fund XI, LLC (Team); Catalio Access Fund X, LLC (Team); Catalio Access Fund IX, LLC (Team); Catalio Access Fund VIII, LLC (Team); Catalio Genesis Fund X, LLC (Team); Catalio Genesis Fund IX, LLC (Team); Catalio Genesis Fund VI, LLC (Team); Catalio Genesis Fund VIII, LLC (Team); Catalio Access Fund VII, LLC (Team); Catalio Genesis Fund V, LLC (Team); Catalio Access Fund VI, LLC (Team); Catalio Genesis Fund IV, LLC (Team); Catalio Genesis Fund III, LLC (Team); Catalio Access Fund V, LLC (Team); Catalio Genesis Fund II, LLC (Team); Catalio Nexus Fund III, LP (Team); CATALIO ACCESS FUND IV, LLC (Team)
- Tom Brooks, Partner
Catalio Access Fund XII, LLC (Team); Catalio Access Fund XI, LLC (Team); Catalio Access Fund X, LLC (Team); Catalio Access Fund IX, LLC (Team); Catalio Access Fund VIII, LLC (Team); Catalio Genesis Fund X, LLC (Team); Catalio Genesis Fund IX, LLC (Team); Catalio Genesis Fund VI, LLC (Team); Catalio Genesis Fund VIII, LLC (Team); Catalio Access Fund VII, LLC (Team); Catalio Genesis Fund V, LLC (Team); Catalio Access Fund VI, LLC (Team); Catalio Genesis Fund IV, LLC (Team); Catalio Genesis Fund III, LLC (Team); Catalio Access Fund V, LLC (Team); Catalio Genesis Fund II, LLC (Team); Catalio Nexus Fund III, LP (Team); CATALIO ACCESS FUND IV, LLC (Team)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- https://cataliocapital.com
- https://cataliocapital.com/
- https://cataliocapital.com/team
- https://cataliocapital.com/portfolio
- https://cataliocapital.com/portfolio/arrivent
- https://cataliocapital.com/portfolio/audicus
- https://cataliocapital.com/portfolio/bayesian-health
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026